Our findings demonstrate that the tumour microenvironment may render TINK cells less tumouricidal and thereby contribute to cancer progression, as CD11b downregulation was detected on TINK cells but not on pNK cells from the NSCLC patients. This evidence concerns the gene ITGAM and neoplasm.